Published on 10 May 2024 on GuruFocus.com via Yahoo Finance
Natalie Holles, Chief Executive Officer of Third Harmonic Bio Inc (NASDAQ:THRD), sold 20,222 shares of the company on May 9, 2024. The transaction was filed on May 10, 2024, as per the SEC Filing.
Warning! GuruFocus has detected 3 Warning Sign with THRD.
Third Harmonic Bio Inc (NASDAQ:THRD) focuses on the development of therapies for inflammatory diseases. The company's approach includes targeting pathways that are critical in the inflammatory process, aiming to provide treatments that are both effective and safe.